Home LiteratureArticle Details
PMID: 16931584 Published · ppublish English Evaluation Study Journal Article

Multiplex pyrosequencing of two polymorphisms in DNA repair gene XRCC1.

The Journal of molecular diagnostics : JMD ·Vol. 8 ·No. 4 ·2006-09-00 ·Pages 444-8

van der Straaten T, Kweekel D, Tiller M, Bogaartz J, Guchelaar HJ

Abstract

DNA repair enzymes play a pivotal role in platinum-based chemotherapy. Within the gene encoding for the base excision repair enzyme XRCC1, several nonsynonymous polymorphisms have been identified. It has been shown that the Arg399Gln single-nucleotide polymorphism results in a polymorphic enzyme that is less capable of initiating DNA repair. We developed a multiplex pyrosequence assay to simultaneously detect two nonsynonymous polymorphisms within the XRCC1 gene. Both of these polymorphisms resulted in amino acid changes: G/A in codon 399 changes Arg into Gln, and deletion of A in the second position of codon 576 results in a stopcodon. We established the frequency of these mutations in 270 patients suffering from colorectal cancer. Allele frequencies of G in second position of codon 399 and A in the second position codon 576 are 61.1 and 99.6%, respectively, in these patients. This fast and reliable method allows for simultaneous detection of the infrequent mutant C or CT alleles instead of the A deletion at codon 576. The method may be used in pharmacogenetic studies of platinum-based chemotherapy.

MeSH Terms
Colorectal Neoplasms/genetics DNA Repair DNA-Binding Proteins/genetics Gene Frequency Genetic Predisposition to Disease Genetic Testing Humans Molecular Sequence Data Mutation Polymerase Chain Reaction Polymorphism, Single Nucleotide Sequence Analysis, DNA/methods X-ray Repair Cross Complementing Protein 1
Chemicals
DNA-Binding Proteins X-ray Repair Cross Complementing Protein 1 XRCC1 protein, human
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
van der Straaten Tahar
Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, P.O. Box 9600, 2300 RA Leiden, The Netherlands. vanderstra@lumc.nl
Kweekel Dinemarie
Tiller Marco
Bogaartz Judith
Guchelaar Henk-Jan
References (17)
17 references, click to expand
  1. Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model?
    Mutat Res. 2000 Jun 30;460(1):1-15 PMID: 10856830
  2. A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer.
    Anticancer Res. 2001 Jul-Aug;21(4B):3075-9 PMID: 11712813
  3. A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.
    Cancer Res. 2001 Dec 15;61(24):8654-8 PMID: 11751380
  4. The impact of pharmacogenomics on gastrointestinal cancer therapy.
    Pharmacogenomics. 2002 Sep;3(5):625-33 PMID: 12223048
  5. Spatial and temporal cellular responses to single-strand breaks in human cells.
    Mol Cell Biol. 2003 Jun;23(11):3974-81 PMID: 12748298
  6. A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage.
    Nucleic Acids Res. 2003 Oct 1;31(19):5526-33 PMID: 14500814
  7. Modulation of DNA repair processes by arsenic and selenium compounds.
    Toxicology. 2003 Nov 15;193(1-2):161-9 PMID: 14599775
  8. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
    Ned Tijdschr Geneeskd. 2003 Nov 8;147(45):2207-12 PMID: 14640057
  9. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.
    J Clin Oncol. 2004 Jul 1;22(13):2594-601 PMID: 15173214
  10. The PARP superfamily.
    Bioessays. 2004 Aug;26(8):882-93 PMID: 15273990
  11. Assignment of a human DNA-repair gene associated with sister-chromatid exchange to chromosome 19.
    Mutat Res. 1986 Aug;174(4):303-8 PMID: 3736579
  12. Iproplatin and carboplatin induced toxicities: overview of phase II clinical trial conducted by the EORTC Early Clinical Trials Cooperative Group (ECTG).
    Eur J Cancer Clin Oncol. 1988 Feb;24(2):255-62 PMID: 3281842
  13. Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand break repair and sister chromatid exchange.
    Mol Cell Biol. 1990 Dec;10(12):6160-71 PMID: 2247054
  14. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans.
    Cancer Res. 1998 Feb 15;58(4):604-8 PMID: 9485007
  15. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency.
    Cancer Res. 1999 Jun 1;59(11):2557-61 PMID: 10363972
  16. 7-Deaza-2'-deoxyadenosine-5'-triphosphate as an alternative nucleotide for the pyrosequencing technology.
    Nucleosides Nucleotides Nucleic Acids. 2004;23(10):1583-94 PMID: 15620097
  17. Advances in the treatment of metastatic colorectal cancer.
    Oncologist. 2005;10 Suppl 3:40-8 PMID: 16368870
Article Info
Journal
The Journal of molecular diagnostics : JMD
Abbr.
J Mol Diagn
ISSN
1525-1578
Published
2006-09-00
Pages
444-8
Language
English
Region
United States
NLM ID
100893612
PMCID
PMC1867628
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com